Roger has been undertaking the role of Chief Executive at The Christie since December 2013.
He has managed significant service developments including networked radiotherapy & chemotherapy centres across Greater Manchester, transforming delivery of Christie services to an outpatient model. He directed the establishment of Christie partnerships for pathology, specialist diagnostic services and private patients, academic investment plan and the establishment of the first national proton therapy service in the UK.
In 2016 he led the Trust to a CQC Outstanding rating, repeated again in 2018. He is in the Top 50 Chief Executives ranked by the HSJ in 2018.
Roger led for Greater Manchester the National Cancer Vanguard developing & testing new models of care and was a member of the long term plan working group. He is the executive lead for Greater Manchester Cancer Alliance.
In December 2018 Roger was appointed to the Healthcare UK Advisory Board. The Advisory Board is accountable to the Department for International Trade (DIT) and Department of Health & Social Care (DHSC) ministers.
Roger holds an MBA, an honours degree in Nursing Studies, is a Registered Nurse and is an independent director of Southway Housing Trust.
Roger previously worked at Salford Royal, East Lancashire Hospitals & Greater Manchester SHA.